Antimycobacterial agents Flashcards
RIPE therapy
TB drugs. All associated with hepatotoxicity; should do 2 phases of treatment for TB: phase 1: 4 drugs for 2 months; phase 2: 2 drugs for 4 months.
rifampin
activates CytP450 and binds DNA dependent RNA pol to inhibit RNA synthesis. Causes orange bodily secretions - i.e. urine.
Can be hepatotoxic especially in combination. Can be nephrotoxic. Can cause flu-like illness when intermittently taken.
Rapid resistance in monotherapy for TB.
Can be used for monotherapy prophylaxis in close contacts of H. influenzae and N. meningitidis patients.
isoniazid (INH)
“lone ranger,” blocks production of mycolic acids at the mycobacteria cell surface. Active only against dividing cells.
INH inhibits CytP450 which causes transient increases of ALT/ liver function tests.
INH = “injury to nerves and hepatocytes” (peripheral neuropathy, seizures, hepatotoxicity)
Can be used for monotherapy in latent TB infections, but most be combined for active therapy.
PZA (pyrazinamide)
“pyro tech knitter,” pro drug, converted to active form in cytoplasm. Blocks alanine synthesis which prevent Vit B6 from activating co-A. Decreased co-A = decreased ATP = cell death. Active against non-dividing and dividing organisms in contrast to INH.
Can cause hyperuricemia and gout. Hepatotoxic.
ethambutol
“Ethel the horse whisperer,” blocks the transferase enzymes that add arabinose sugars to the cell wall’s lipoarabinomannan and arabinogalactin.
Bacteriostatic - does not kill directly but inhibits replication/proliferation.
Side effect: optic neuritis, red and green colorblindness
aminoglycosides/ streptomycin
first anti-TB drugs; binds the 30s ribosome subunit inhibiting proper translation of the bacterium’s proteins = lethal. Resistance emerged. Also caused toxicity to cranial nerve 8 = hearing issues, balance issues.
bedaquiline
binds and inhibits mycobacterial ATP synthase (preferentially over euk version- so we good), which causes mycobacterial cell death due to lack of energy and lack of ability to regulate ion concentrations.
Toxicity: prolonged QT interval, chest pain, hemoptysis, hepatitis
clofazimine
highly lipophilic dye / oxidizing agent that disrupts the cell membrane in mycobacteria, pulling away e- from ETC and thus increasing antibacterial ROS. Used in combo with dapsone and rifampin for leprosy.
Can also be used for MDR Tb therapy.
Toxicity: GI upset, brownish black skin discoloration